Guardant Health (GH) Operating Leases (2019 - 2026)

Guardant Health has disclosed Operating Leases across 8 years of filings, most recently posting $173.1 million for Q1 2026.

• Operating Leases for Q1 2026 came in at $173.1 million, down 8.94% year-over-year; the trailing twelve-month figure through Mar 2026 was $173.1 million (down 8.94% YoY), and the FY2025 annual result was $178.5 million, up 8.63% from the prior year.
• Operating Leases came in at $173.1 million for Q1 2026 at Guardant Health, down from $178.5 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $240.8 million in Q2 2022 to a low of $164.3 million in Q4 2024.
• The 5-year median for Operating Leases is $199.9 million (2024), against an average of $200.5 million.
• Across the five-year window, Operating Leases advanced 13.7% in 2022 and dropped 22.33% in 2024, its largest moves.
• Guardant Health's Operating Leases stood at $210.0 million in 2022, then slipped by 11.51% to $185.8 million in 2023, then retreated by 11.6% to $164.3 million in 2024, then advanced by 8.63% to $178.5 million in 2025, then declined by 3.03% to $173.1 million in 2026.
• The last three Operating Leases figures came in at $173.1 million (Q1 2026), $178.5 million (Q4 2025), and $185.4 million (Q3 2025), per Business Quant data.